Found: 5
Select item for more details and to access through your institution.
T cells and their products in diabetic kidney disease.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2023.1084448
- By:
- Publication type:
- Article
Mitochondrial metabolic reprogramming in diabetic kidney disease.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 6, p. 1, doi. 10.1038/s41419-024-06833-0
- By:
- Publication type:
- Article
FTO‐mediated m6A modification of serum amyloid A2 mRNA promotes podocyte injury and inflammation by activating the NF‐κB signaling pathway.
- Published in:
- FASEB Journal, 2024, v. 38, n. 2, p. 1, doi. 10.1096/fj.202301419RR
- By:
- Publication type:
- Article
The causal role between circulating immune cells and diabetic nephropathy: a bidirectional Mendelian randomization with mediating insights.
- Published in:
- Diabetology & Metabolic Syndrome, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13098-024-01386-w
- By:
- Publication type:
- Article
N6-methyladenosine methylation in kidney injury.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01586-7
- By:
- Publication type:
- Article